Results 71 to 80 of about 225,355 (264)

Determinants and Equity Evaluation for Health Expenditure Among Patients with Rare Diseases in China

Chinese Medical Journal, 2016
Background: China has not established social security system for rare diseases. Rare diseases could easily impoverish patients and their families. Little research has studied the equity and accessibility of health services for patients with rare diseases
Xiao-Xiong Xin, Liang Zhao, Xiao-Dong Guan, Lu-Wen Shi   +3 more
doaj   +1 more source

Complementarity of Long‐Reads and Optical Mapping in Parkinson's Disease for Structural Variants

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Long‐read sequencing and optical genome mapping technologies have the ability to detect large and complex structural variants. This has led to the discovery of novel pathogenic variants in neurodegenerative movement disorders. Thus, we aimed to systematically compare the SV detection capabilities of OGM and ONT in Parkinson's disease.
André Fienemann, Theresa Lüth, Susen Schaake, Carolin Gabbert, Marius Möller, Hauke Busch, Katja Lohmann, Jonas A. Gustafson, Danny E. Miller, Kensuke Daida, Manabu Funayama, Nobutaka Hattori, Samia Ben Sassi, Faycel Hentati, Matthew J. Farrer, Kristian K. Ullrich, Christine Klein, Joanne Trinh   +17 more
wiley   +1 more source

A Study on Disease Episodes and the Expenditure Incurred by the Families of an Urban Area of Karnataka

National Journal of Community Medicine, 2017
Background: In many developing countries, a large proportion of the money spent on health care comes from the out-of-pocket expenditure of patients or their families.
Dayalaxmi T Shedole, Panchsheela S Reshmi, Sidramappa S Reshmi, Sneha K Kamble, Nazir AD Bendigiri   +4 more
doaj  

Government health expenditure in India

Bulletin of the World Health Organization, 2015
In their paper about progress towards universal health coverage in Brazil, the Russian Federation, India, China, South Africa (BRICS),1 Rao et al. report that in India in 2011, of total government expenditure, about 8% was expended on health. This estimate was from the World Health Organization’s (WHO’s) global health observatory data respository,2 ...
openaire   +2 more sources

Validity of a Wearable Digital Insole for Assessing Gait ON and OFF in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Gait impairment is a distinctive symptom of Parkinson's disease that negatively impact mobility. We assessed the validity of wearable digital insoles against a validated reference gait analysis system for measuring select gait characteristics in patients with Parkinson's disease. Methods A comparative analysis between digital insoles
Deborah A. Hall, Kimberly Kwei, Rolando J. Acosta, Bharatkumar Koyani, Erin Robertson, Pratyush Rai, Roland Barge, Emily Timm, Nicollette L. Purcell, Natasha Desai, Dhanesh Patel, Ana‐Maria Visoiu‐Knapp, Samuel Stuart, Rinol Alaj, Matthew F. Wipperman, Oren Levy, Joan A. O'Keefe   +16 more
wiley   +1 more source

Does the leading pharmaceutical reform in China really solve the issue of overly expensive healthcare services? Evidence from an empirical study.

PLoS ONE, 2018
BackgroundHealthcare system reform of Sanming city has become a leading healthcare reform model in China. It has developed a rigorous pharmaceutical reform consisted of the Zero Mark-up Drug Policy and the Centralized Procurement of Medicine Policy to ...
Yunzhen He, Guanshen Dou, Qiaoyun Huang, Xinyu Zhang, Yingfeng Ye, Mengcen Qian, Xiaohua Ying   +6 more
doaj   +1 more source

Health worker remuneration in WHO Member States

Bulletin of the World Health Organization, 2013
Objective To present the available data on the money spent by Member States of the World Health Organization (WHO) on remunerating health workers in the public and private sectors.
P Hernandez-Pena, JP Poullier, CJM Van Mosseveld, N Van de Maele, V Cherilova, C Indikadahena, G Lie, T Tan-Torres, David B Evans   +8 more
doaj   +1 more source

Plasma EV Proteomics Identifies ECM Remodeling and Inflammatory Proteins LUM and C7 as Candidate Biomarkers in FSHD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy (FSHD) is one of the most debilitating and common muscular dystrophies. Despite its severity, no approved therapy exists for FSHD patients. However, several therapeutic candidates are currently under development, and some have recently entered clinical trials, marking the need for reliable ...
Mustafa Bilal Bayazit, Chiranth K. Nagaraj, Jackson S. Newell, Kim Truc Nguyen, Xilal Y. Rima, Jacob Doon‐Ralls, Eduardo Reátegui, Jeffrey M. Statland, Rabi Tawil, Kevin M. Flanigan, Scott Q. Harper, Nizar Y. Saad   +11 more
wiley   +1 more source

Advancing Stroke Clinical Trials Using Community Engagement and Implementation Science Approaches

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Stroke clinical trials are essential for advancing stroke care but can face challenges with recruitment, retention, clinical relevance, and translation into real‐world practice. We propose that integrating community engagement and implementation science approaches into stroke trials can help address these needs.
Lesli E. Skolarus, Devin L. Brown, Bernadette Boden‐Albala   +2 more
wiley   +1 more source

Catastrophic health-care expenditure and willingness to pay for health insurance in a metropolitan city: A cross-sectional study

Indian Journal of Community Medicine, 2018
Background: Health insurance can be a very useful strategy to mitigate the disabling effects of catastrophic health expenditure in India. Objectives: The aim of the study is to estimate catastrophic health expenditure incurred and the willingness to pay ...
Rujuta Sachin Hadaye, Jerome Gnanasigamony Thampi   +1 more
doaj   +1 more source